32362 Federal Register / Vol. 66, No. 115 / Thursday, June 14, 2001 / Notices

(NIH) has submitted to the Office of

Management and Budget (OMB) a

request for review and approval of the

information collection listed below.

This proposed information collection

was previously published in the Federal

Register on November 15, 2000, page

69031–69032 and allowed 60-days for

public comment. No public comments

were received. The purpose of this

notice is to allow an additional 30 days

for public comment. The National

Institutes of Health may not conduct or

sponsor, and the respondent is not

required to respond to, an information

collection that has been extended,

revised, or implemented on or after

October 1, 1995, unless it displays a

currently valid OMB control number.

Proposed Collection

Title: The Jackson Heart Study:

Annual Follow-up with Third Party

Respondents Type of Information

Collection Request: New, Need and Use

of Information Collection: This is a

request for collection of follow-up

information from third party individuals

(next-of-kin descendants and

physicians) for the participants in the

Jackson Heart Study (JHS) Follow up.

The information is necessary to

complete the determination of causes of

morbidity and mortality in the JHS

Cohort. The initial examination phase of

the study began in the fall of 2000 and

will take approximately three years to

complete. Annual follow-up will begin

one year after the initial exam, in the

Fall of 2001. The information collected

will be used by the public and private

sector for public health planning,

medical education, other epidemiologic

studies, and biomedical. Frequency of

Response: One-Time. Affected Public:

Individuals or families; Businesses or

other for profit; Not-for-profit

institutions. Type of Respondents: Third

party respondents (next-of-kin

decedents and physicians). The annual

reporting burden is as follows:

Estimated Number of Respondents: 480.

Estimated Number of Responses per

Respondent: 1. Average Burden Hours

Per Response: 0.333. Estimated Total

Annual Burden Hours Requested: 160.

The annualized cost to respondents is

estimated at: $3,600. There are no

Capital Costs, Operating Costs or

Maintenance Costs to report.

Estimates of the annual reporting

burden to respondents:

Type of respondents

Estimated

number of

respondents

Estimated

number of responses per

respondent

Average burden hours per

response

Estimated total

annual burden

hours

requested

Morbidity & Mortality AFU 3rd party next-of-kin decedents ............................ 240 1 0.33 80

Morbidity & Mortality AFU 3rd party Physicians .............................................. 240 1 0.33 80

Total .......................................................................................................... 480 ........................ ........................ 160

Request for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the function of the agency, including

whether the information will have

practical utility; (2) The accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumption used; (3)

Ways to enhance the quality, utility, and

clarity of the information to be

collected; and (4) Ways to minimize the

burden of the collection of information

on those who are to respond, including

the use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology.

Direct Comments to OMB

Written comments and/or suggestions

regarding the item(s) contained in this

notice, especially regarding the

estimated public burden associated

response time, should be directed to the:

Office of Management and Budget,

Office of Regulatory Affairs, New

Executive Office Building, Room 10235,

Washington, DC 20503, Attention: Desk

Officer for NIH. To request more

information on the proposed project or

to obtain a copy of the data collection

plans and instruments, contact: Ms.

Cheryl Nelson, Epidemiology and

Biometry Program, Division of

Epidemiology and Clinical

Applications, NHLBI, NIH, II Rockledge

Centre, 6701 Rockledge Drive, room

8152, Bethesda, MD, 20892, or call nontoll-free number (301) 435–0451, or email your request, including your

address to: cn80n@nih.gov.

Comments Due Date: Comments

regarding the information collection are

best assured of having their full effected

if received on or before July 16, 2001.

Peter J. Savage,

Acting Director, Division of Epidemiology and

Clinical Applications, NHLBI.

[FR Doc. 01–14973 Filed 6–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel In Vivo

Cellular and Molecular Imaging Centers.

Date: July 18–19, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriot, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Timothy C. Meeker, MD.,

Scientific Review Administrator, Special

Referral and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, 6116 Executive Boulevard, room

8088, Rockville, MD 20852, 301/594–1279.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Federal Register / Vol. 66, No. 115 / Thursday, June 14, 2001 / Notices 32363

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 7, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14965 Filed 6–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. the grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Innovative

Technologies for the Molecular Analysis of

Cancer.

Date: July 18–20, 2001.

Time: 7 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Thomas M. Vollberg, PhD,

Scientific Review Administrator, Special

Review, Referral and Resources Branch,

Division of Extramural Activities, National

Cancer Institute, National Institute of Health,

6116 Executive Boulevard, Room 8049,

Rockville, MD 20852, 301/594–9582.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis; 93.395, Cancer Treatment

Research; 93.396, Cancer Biology Research;

93.397, Cancer Centers Support; 93.398,

Cancer Research Manpower; 93.399, Cancer

Control, National Institutes of Health, HHS)

Dated: June 7, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14966 Filed 6–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

could constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Small

Grants Program for Cancer Epidemiology.

Date: July 17–18, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 8120 Wisconsin Ave.,

Bethesda, MD 20814.

Contact Person: Mary Jane Slesinski, PhD.,

Scientific Review Administrator, Special

Review and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 8045, Bethesda,

MD 20892, 301/594–1566.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: June 7, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14967 Filed 6–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Exposure

Assessment Methods for Cancer Research.

Date: July 16–17, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Bethesda, 8120

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Lalita D. Palekar, PhD,

Scientific Review Administrator, Special

Review, Referral and Resources Branch,

Division of Extramural Activities, National

Cancer Institute, National Institutes of

Health, 6116 Executive Boulevard, Room

8105, Bethesda, MD 20892–7405, (301) 496–

7575.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or profession

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)